Better Vaccine Stock: Ocugen vs. Inovio Pharmaceuticals

The pandemic is dragging on. With the newer and more contagious omicron variant of the virus that causes COVID-19 now spreading quickly, we aren't out of the woods just yet. These latest developments again highlight the importance of potent vaccines as a tool to fight the outbreak.

And while there are plenty of companies already offering vaccines, two biotechs that still plan to make some noise in this market are Ocugen (NASDAQ: OCGN) and Inovio Pharmaceuticals (NASDAQ: INO). These vaccine makers are underdogs, but which one is more likely to perform well in 2022 and beyond? Let's look closer into both companies' businesses and pick a likely winner.

Data by YCharts.

Continue reading

Source Fool.com